+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Preeclampsia Drug"

Preeclampsia Drugs Market Report 2025 - Product Thumbnail Image

Preeclampsia Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Preeclampsia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Preeclampsia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Preeclampsia is a serious medical condition that can occur during pregnancy and is characterized by high blood pressure and protein in the urine. It can lead to serious complications for both the mother and the baby. Treatment for preeclampsia typically involves medications to lower blood pressure and reduce the risk of complications. Sexual and reproductive health drugs are used to treat a variety of conditions related to sexual and reproductive health, including preeclampsia. These drugs are used to reduce the risk of complications associated with preeclampsia, such as seizures, stroke, and organ damage. They can also help to reduce the risk of preterm birth and improve the health of the mother and baby. Common medications used to treat preeclampsia include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers. Some of the companies in the preeclampsia drug market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Show Less Read more